Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.

Reason D, Liberato J, Sun J, Keitel W, Zhou J.

Infect Immun. 2009 May;77(5):2030-5. doi: 10.1128/IAI.01254-08. Epub 2009 Feb 17.

PMID:
19223482
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Molecular basis for improved anthrax vaccines.

Brey RN.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. Epub 2005 Apr 21. Review.

PMID:
15935874
[PubMed - indexed for MEDLINE]
3.

Progress and novel strategies in vaccine development and treatment of anthrax.

Chitlaru T, Altboum Z, Reuveny S, Shafferman A.

Immunol Rev. 2011 Jan;239(1):221-36. doi: 10.1111/j.1600-065X.2010.00969.x. Review.

PMID:
21198675
[PubMed - indexed for MEDLINE]
4.

Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.

Bouzianas DG.

Expert Rev Anti Infect Ther. 2007 Aug;5(4):665-84. Review.

PMID:
17678429
[PubMed - indexed for MEDLINE]
5.

Past, imminent and future human medical countermeasures for anthrax.

Baillie LW.

J Appl Microbiol. 2006 Sep;101(3):594-606. Review.

PMID:
16907809
[PubMed - indexed for MEDLINE]
6.

Recent progress in the development of anthrax vaccines.

Kaur M, Bhatnagar R.

Recent Pat Biotechnol. 2011 Dec;5(3):148-59. Review.

PMID:
22360464
[PubMed - indexed for MEDLINE]
7.

Monoclonal antibody therapies against anthrax.

Chen Z, Moayeri M, Purcell R.

Toxins (Basel). 2011 Aug;3(8):1004-19. doi: 10.3390/toxins3081004. Epub 2011 Aug 15. Review.

PMID:
22069754
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Is new always better than old?: The development of human vaccines for anthrax.

Baillie LW.

Hum Vaccin. 2009 Dec;5(12):806-16. Epub 2009 Dec 9. Review.

PMID:
19786839
[PubMed - indexed for MEDLINE]
Free Article
9.

Anthrax lethal toxin and the induction of CD4 T cell immunity.

Ascough S, Ingram RJ, Altmann DM.

Toxins (Basel). 2012 Oct;4(10):878-99. doi: 10.3390/toxins4100878. Epub 2012 Oct 19. Review.

PMID:
23162703
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Development of an improved vaccine for anthrax.

Leppla SH, Robbins JB, Schneerson R, Shiloach J.

J Clin Invest. 2002 Jul;110(2):141-4. Review. No abstract available.

PMID:
12122102
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antibodies against anthrax: mechanisms of action and clinical applications.

Froude JW 2nd, Thullier P, Pelat T.

Toxins (Basel). 2011 Nov;3(11):1433-52. doi: 10.3390/toxins3111433. Epub 2011 Nov 16. Review.

PMID:
22174979
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties.

Kamarajugadda S, Daniell H.

Expert Rev Vaccines. 2006 Dec;5(6):839-49. Review.

PMID:
17184221
[PubMed - indexed for MEDLINE]
13.

Monoclonal antibodies and toxins--a perspective on function and isotype.

Chow SK, Casadevall A.

Toxins (Basel). 2012 Jun;4(6):430-54. doi: 10.3390/toxins4060430. Epub 2012 Jun 11. Review.

PMID:
22822456
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Passive antibody administration (immediate immunity) as a specific defense against biological weapons.

Casadevall A.

Emerg Infect Dis. 2002 Aug;8(8):833-41. Review.

PMID:
12141970
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Ricin vaccine development.

Smallshaw JE, Vitetta ES.

Curr Top Microbiol Immunol. 2012;357:259-72. doi: 10.1007/82_2011_156. Review.

PMID:
21805396
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk